AKT1 and Insulin resistance: Studies have shown that in the setting of insulin resistance, the activation of the AKT/FOXO1 signaling pathway is reduced; consequently, FOXO1 activity is enhanced, which promotes hepatic gluconeogenic gene expression, leading to increased blood glucose levels (Accili and Arden, 2004).